AXIM - AXIM Biotechnologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
24.58M
Enterprise Value 3
30.77M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
36.15
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
45.24
Enterprise Value/EBITDA 6
-5.15

Trading Information

Stock Price History

Beta (5Y Monthly) -5.81
52-Week Change 3-66.21%
S&P500 52-Week Change 326.13%
52 Week High 32.5000
52 Week Low 30.3500
50-Day Moving Average 30.4179
200-Day Moving Average 30.5810

Share Statistics

Avg Vol (3 month) 365.05k
Avg Vol (10 day) 3120.67k
Shares Outstanding 563.04M
Float 17.49M
% Held by Insiders 168.59%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-879.48%

Management Effectiveness

Return on Assets (ttm)-235.99%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)680.13k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)6,375.10%
Gross Profit (ttm)187.1k
EBITDA -5.98M
Net Income Avi to Common (ttm)-5.99M
Diluted EPS (ttm)-0.1000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.6M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)7.66M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.65
Book Value Per Share (mrq)-0.10

Cash Flow Statement

Operating Cash Flow (ttm)-4.67M
Levered Free Cash Flow (ttm)-2.24M